Association of Epstein-Barr virus infection and pulmonary exacerbations in patients with cystic fibrosis.
We observed severe pulmonary exacerbations during primary Epstein-Barr virus (EBV) infection in adolescent patients with cystic fibrosis. Since EBV is not a known respiratory tract pathogen in cystic fibrosis, we studied retrospectively all EBV-susceptible patients ages 6 to 18 years with chronic Pseudomonas respiratory tract colonization hospitalized for a pulmonary exacerbation during an 18-month period. Patients with serologic evidence of primary EBV infection (n = 5) were compared to control patients without EBV (n = 7). Before admission the groups had similar pulmonary function tests, clinical scores and frequency of hospitalization. On admission patients with EBV had significant weight loss, lower pulmonary function tests and lower clinical scores compared with controls. All remained significantly different 6 months after admission. Frequency of exacerbations requiring hospitalization increased after EBV infection but remained unchanged in controls. Primary EBV infection can be associated with severe pulmonary exacerbations and subsequent deterioration in clinical course in cystic fibrosis patients.
Winnie
G B
GB
Department of Pediatrics, Albany Medical College, NY 12208.
Cowan
R G
RG
D000293:Adolescent; D002648:Child; D003550:Cystic Fibrosis / Q000150:complications*; D005260:Female; D006566:Herpesviridae Infections / Q000150:complications* / Q000175:diagnosis; D004854:Herpesvirus 4, Human; D006801:Humans; D008297:Male; D011552:Pseudomonas Infections / Q000150:complications*; D012141:Respiratory Tract Infections / Q000150:complications* / Q000382:microbiology; D012189:Retrospective Studies; D012698:Serologic Tests